Pia Lundman

Publications
Grants
CV
Public outreach and news

Articles

Article: CYTOKINE. 2024;182:156696

Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarction

Cederstrom S; Jernberg T; Samnegard A; Johansson F; Silveira A; Tornvall P; Lundman P
Journal article: CARDIOVASCULAR DIABETOLOGY. 2024;23(1):290

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Ritsinger V; Avander K; Lagerqvist B; Lundman P; Norhammar A
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2024;:zwae190

Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals

Yari A; Ueda P; Lundman P; Alfredsson J; Ravn-Fischer A; Soderberg S; Yndigegn T; Hagstrom E; Jernberg T
Article: CLINICAL KIDNEY JOURNAL. 2024;17(3):sfae050

Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function

Salzinger B; Lundwall K; Evans M; Moertberg J; Wallen H; Jernberg T; Kahan T; Lundman P; Tornvall P; Erlinge D; Lindahl B; Baron T; Rezeli M; Spaak J; Jacobson SH
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.1232

Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry

Ritsinger V; Avander K; Lagerqvist B; Lundman P; Norhammar A
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.1421

Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction

Cederstrom S; Johansson F; Samnegard A; Silveira A; Tornvall P; Jernberg T; Lundman P
Article: JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2023;37(10):108599

Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial

Ritsinger V; Hagstrom E; Hambraeus K; James S; Jernberg T; Lagerqvist B; Leosdottir M; Lundman P; Pernow J; Ostlund O; Norhammar A
Article: SCIENTIFIC REPORTS. 2023;13(1):12171

Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population

Cederstrom S; Lundman P; Alfredsson J; Hagstrom E; Ravn-Fischer A; Soderberg S; Yndigegn T; Tornvall P; Jernberg T
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023;81(6):400-410

Statin Treatment Intensity, Discontinuation, and Long-Term Outcome in Patients With Acute Myocardial Infarction and Impaired Kidney Function

Khedri M; Szummer K; Lundman P; Jernberg T; Desta L; Lindahl B; Erlinge D; Jacobson SH; Spaak J
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2023;373:64-71

Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function

Mortberg J; Salzinger B; Lundwall K; Edfors R; Jacobson SH; Wallen HN; Jernberg T; Baron T; Erlinge D; Andell P; James S; Eggers KM; Hjort M; Kahan T; Lundman P; Tornvall P; Rezeli M; Marko-Varga G; Lindahl B; Spaak J
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11S):530

Impact of Kidney Function on the Association Between Selected Proteomic Biomarkers and Cardiovascular Events and Mortality

Salzinger B; Lundwall K; Evans M; Mortberg JL; Wallen H; Jernberg T; Kahan T; Lundman P; Lindahl B; Spaak J; Jacobson SH
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2022;29(13):1759-1769

Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study

Karayiannides S; Norhammar A; Landstedt-Hallin L; Friberg L; Lundman P
Article: CARDIOVASCULAR DIABETOLOGY. 2021;20(1):227

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure

Lind V; Hammar N; Lundman P; Friberg L; Talback M; Walldius G; Norhammar A
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1061-1070

Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction

Tengbom J; Cederstrom S; Verouhis D; Bohm F; Eriksson P; Folkersen L; Gabrielsen A; Jernberg T; Lundman P; Persson J; Saleh N; Settergren M; Sorensson P; Tratsiakovich Y; Tornvall P; Jung C; Pernow J
Article: CARDIOVASCULAR DIABETOLOGY. 2021;20(1):122

Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c

Karayiannides S; Djupsjo C; Kuhl J; Hofman-Bang C; Norhammar A; Holzmann MJ; Lundman P
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(2):104-111

Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction

Trevisan M; Fu EL; Szummer K; Norhammar A; Lundman P; Wanner C; Sjoelander A; Jernberg T; Carrero JJ
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2021;7(1):59-67

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17

Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2020;17(6):1479164120973676-147916412097367

Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry

Ritsinger V; Lagerqvist B; Lundman P; Hagstrom E; Norhammar A
Article: JOURNAL OF INTERNAL MEDICINE. 2020;288(5):581-592

Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction

Edfors R; Lindhagen L; Spaak J; Evans M; Andell P; Baron T; Mortberg J; Rezeli M; Salzinger B; Lundman P; Szummer K; Tornvall P; Wallen HN; Jacobson SH; Kahan T; Marko-Varga G; Erlinge D; James S; Lindahl B; Jernberg T
Article: EUROPEAN HEART JOURNAL. 2020;41(40):3900-3909

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study

Allahyari A; Jernberg T; Hagstrom E; Leosdottir M; Lundman P; Ueda P
Article: OPEN HEART. 2020;7(1):e001217

Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass grafting

Djupsjo C; Sartipy U; Ivert T; Karayiannides S; Lundman P; Nystrom T; Holzmann MJ; Kuhl J
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(1):66-77

New candidate genes for ST-elevation myocardial infarction

Cederstrom S; Lundman P; Folkersen L; Paulsson-Berne G; Karadimou G; Eriksson P; Caidahl K; Gabrielsen A; Jernberg T; Persson J; Tornvall P
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz746.1187

P6599Upregulation of protein and gene expression of arginase-1 in patients with ST elevation myocardial infarction

Tengbom J; Cederstrom S; Verouhis D; Sorensson P; Bohm F; Saleh N; Jernberg T; Lundman P; Eriksson P; Gabrielsen A; Caidahl K; Persson J; Folkersen L; Tornvall P; Pernow J
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz747.0056

209Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects

Lind V; Hammar N; Lundman P; Friberg L; Tallback M; Walldius G; Norhammar A
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz747.0427

P828Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Article: CLINICAL BIOCHEMISTRY. 2019;64:24-29

Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis

Palmer MK; Barter PJ; Lundman P; Nicholls SJ; Toth PP; Karlson BW
Article: JOURNAL OF INTERNAL MEDICINE. 2018;284(6):674-684

Genetic testing for familial hypercholesterolemia among survivors of acute coronary syndrome

Benedek P; Eriksson M; Duvefelt K; Freyschuss A; Frick M; Lundman P; Nylund L; Szummer K
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy563.p3674

P3674New candidate genes for plaque rupture in myocardial infarction

Cederstrom S; Lundman P; Folkersen L; Paulsson-Berne G; Eriksson P; Caidahl K; Gabrielsen A; Jernberg T; Persson J; Tornvall P
Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2018;40(3):251-257

VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia

Silveira A; Carlo A; Adam M; McLeod O; Lundman P; Boquist S; Woodhams BJ; Hamsten A
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2018;15(1):31-38

High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report

Karayiannides S; Lundman P; Friberg L; Norhammar A
Article: CARDIOLOGY. 2018;140(1):30-34

Modeling Statin-Induced Reductions of Cardiovascular Events in Primary Prevention: A VOYAGER Meta-Analysis

Karlson BW; Nicholls SJ; Lundman P; Barter PJ; Palmer MK
Article: ATHEROSCLEROSIS. 2017;265:54-59

Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database

Karlson BW; Palmer MK; Nicholls SJ; Barter PJ; Lundman P
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx493.p5545

P5545Higher one-year mortality in patients with diabetes mellitus and ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention - a TASTE substudy

Karayiannides S; Norhammar A; Froebert O; James S; Lagerqvist B; Lundman P
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(4):212-217

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER

Karlson BW; Wiklund O; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2016;13(4):307-311

Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study

Arnetz L; Hage C; Brismar K; Catrina S-B; Norhammar A; Lundman P; Wallander M; Ryden L; Mellbin L
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2016;23(7):744-747

Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2016;117(9):1444-1448

A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: CARDIOVASCULAR DIABETOLOGY. 2015;14:120

Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia

Kuhl J; Jorneskog G; Wemminger M; Bengtsson M; Lundman P; Kalani M
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2015;4(8):e001853

Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease

Persson J; Strawbridge RJ; McLeod O; Gertow K; Silveira A; Baldassarre D; Van Zuydam N; Shah S; Fava C; Gustafsson S; Veglia F; Sennblad B; Larsson M; Sabater-Lleal M; Leander K; Gigante B; Tabak A; Kivimaki M; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Humphries SE; Tremoli E; de Faire U; Lind L; Ingelsson E; Hedblad B; Melander O; Kumari M; Hingorani A; Morris AD; Palmer CNA; Lundman P; Ohrvik J; Soderberg S
Article: ATHEROSCLEROSIS. 2015;241(2):450-454

To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2014;11(4):290-293

The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study

Hage C; Brismar K; Lundman P; Norhammar A; Ryden L; Mellbin L
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2013;20(6):1080-1087

Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: An analysis from the VOYAGER database

Palmer MK; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
Article: CLINICAL SCIENCE. 2013;125(7-8):401-407

CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation

Paramel GV; Folkersen L; Strawbridge RJ; Elmabsout AA; Sarndahl E; Lundman P; Jansson J-H; Hansson GK; Sirsjo A; Fransen K
Journal article: EUROPEAN HEART JOURNAL. 2013;34(suppl_1):p4289

The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations

Hage C; Brismar K; Lundman P; Mellbin L; Ryden L
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2013;20(4):549-554

Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes

Hage C; Lundman P; Ryden L; Mellbin L
Article: ATHEROSCLEROSIS. 2013;228(1):265-269

Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥50% reduction in high-risk patients: Results from VOYAGER

Karlson BW; Nicholls SJ; Lundman P; Palmer MK; Barter PJ
Article: JOURNAL OF INTERNAL MEDICINE. 2013;273(4):410-421

Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities-the BEGAMI study

Hage C; Brismar K; Efendic S; Lundman P; Ryden L; Mellbin L
Article: ATHEROSCLEROSIS. 2012;225(2):491-496

High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis

Persson J; Folkersen L; Ekstrand J; Helleberg J; Gabrielsen A; Lundman P; Hedin U; Paulsson-Berne G
Article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 2012;22(9):697-703

Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: Results from VOYAGER

Karlson BW; Barter PJ; Palmer MK; Lundman P; Nicholls SJ
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2012;19(2):221-230

Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada

Gitt AK; Drexel H; Feely J; Ferrieres J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Juenger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJP
Article: DIABETIC MEDICINE. 2011;28(11):1343-1351

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

Leiter LA; Lundman P; da Silva PM; Drexel H; Juenger C; Gitt AK
Article: KIDNEY INTERNATIONAL. 2011;79(9):997-1004

Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction

Szummer K; Lundman P; Jacobson SH; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Article: JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 2011;31(2):259-264

Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case-Control Study

Bennermo M; Nordin M; Lundman P; Boqvist S; Held C; Samnegard A; Ericsson C-G; Silveira A; Hamsten A; Nastase MM; Tornvall P
Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(2):194-205

Low plasma adiponectin concentration is associated with myocardial infarction in young individuals

Persson J; Lindberg K; Gustafsson TP; Eriksson P; Paulsson-Berne G; Lundman P
Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(1):40-49

Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register

Szummer K; Lundman P; Jacobson SH; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Article: AMERICAN HEART JOURNAL. 2010;159(6):979-986

Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: Data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

Szummer K; Lundman P; Jacobson SH; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Article: LAKARTIDNINGEN. 2009;106(50-51):3430-3434

[Chest pain in women with low risk of coronary disease. Think of coronary artery dissection].

Rohman H; Lundman P; Sarkar N; Wallén H
Article: CIRCULATION. 2009;120(10):851-U55

Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

Szummer K; Lundman P; Jacobson SH; Schoen S; Lindbaeck J; Stenestrand U; Wallentin L; Jernberg T
Article: ATHEROSCLEROSIS. 2009;204(2):424-428

Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins

Patel S; Puranik R; Nakhla S; Lundman P; Stocker R; Wang XS; Lambert G; Rye K-A; Barter PJ; Nicholls SJ; Celermajer DS
Journal article: ATHEROSCLEROSIS PLUS. 2009;10(2):e417

Abstract: 1068 LOW ADIPONECTIN CONCENTRATION IS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND LEVELS ARE INFLUENCED BY GENETIC VARIANTS

Persson J; Eriksson P; Gustafsson T; Berne GP; Lundman P
Journal article: CANADIAN JOURNAL OF DIABETES. 2009;33(3):242

Characteristics of statin-treated patients with diabetes mellitus in Europe and canada: results of the Dyslipidemia International study

Leiter L; Feely J; Ferrieres J; Gitt A; Gonzalez-Juanatey JR; Thomsen KK; Lundman P; da Silva PM; Pedersen T; Wood D; Kastelein J; Drexel H
Journal article: CIRCULATION. 2008;118(suppl_18)

Abstract 5579: Myocardial Infarction, Clinical Characteristics and Prognosis across Five Renal Function Stages - Data from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)

Szummer K; Lundman P; Jacobson S; Schön S; Lindbäck J; Stenestrand U; Wallentin L; Jernberg T
Journal article: FUTURE CARDIOLOGY. 2007;3(2):157-164

Impact of statins on atherosclerotic plaque.

Nicholls SJ; Chhatriwalla AK; Lundman P
Article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 2007;17(3):195-202

A high-fat meat is accompanied by increased plasma interleukin-6 concentrations

Lundman P; Boquist S; Samnegard A; Bennermo M; Held C; Ericsson C-G; Silveira A; Hamsten A; Tornvall P
Journal article: HEART LUNG AND CIRCULATION. 2007;16:s167-s168

Transient Triglyceridaemia Reduces the Anti-inflammatory Properties of High-density Lipoprotein

Patel S; Puranik R; Nakhla S; Lundman P; Rye K; Barter PJ; Nicholls SJ; Celermajer DS
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2006;48(4):715-720

Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function

Nicholls SJ; Lundman P; Harmer JA; Cutri B; Griffiths KA; Rye K-A; Barter PJ; Celermajer DS
Article: JOURNAL OF INTERNAL MEDICINE. 2005;258(5):411-419

Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction

Samnegård A; Silveira A; Lundman P; Boquist S; Odeberg J; Hulthe J; Mcpheat W; Tornvall P; Bergstrand L; Ericsson CG; Hamsten A; Eriksson P
Journal article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2005;105(1):40-45

Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro.

Sieveking DP; Woo K-S; Fung KP; Lundman P; Nakhla S; Celermajer DS
Article: JOURNAL OF INTERNAL MEDICINE. 2005;257(5):415-422

Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene

Lundberg GA; Kellin A; Samnegård A; Lundman P; Tornvall P; Dimmeler S; Zeiher AM; Hamsten A; Hansson GK; Eriksson P
Article: NATURE GENETICS. 2005;37(5):486-494

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

Swanberg M; Lidman O; Padyukov L; Eriksson P; Åkesson E; Jagodic M; Lobell A; Khademi M; Borjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
Journal article: DIABETIC MEDICINE. 2005;22(3):355-356

New carotid plaque formation is very common in adult patients with Type 2 diabetes mellitus.

Lundman P; Keech AC; Griffiths K; Pillai A; Celermajer DS
Article: THROMBOSIS AND HAEMOSTASIS. 2005;93(3):570-577

Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction

Mannila MN; Eriksson P; Lundman P; Samnegård A; Boquist S; Ericsson CG; Tornvall P; Hamsten A; Silveira A
Article: ATHEROSCLEROSIS. 2005;178(1):193-198

A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein

Kovacs A; Green F; Hansson LO; Lundman P; Samnegård A; Boquist S; Ericsson CG; Watkins HH; Hamsten A; Tornvall P
Article: THROMBOSIS AND HAEMOSTASIS. 2004;92(5):1122-1128

Effect of interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe

Kelberman D; Hawe E; Luong LA; Mohamed-Ali V; Lundman P; Tornvall P; Aillaud MF; Juhan-Vague I; Yudkin JS; Margaglione M; di Minno G; Tremoli E; Humphries SE
Article: METABOLISM-CLINICAL AND EXPERIMENTAL. 2004;53(7):852-857

Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: The HIFMECH study

Yudkin JS; Juhan-Vague I; Hawe E; Humphries SE; di Minno G; Margaglione M; Tremoli E; Kooistra T; Morange PE; Lundman P; Mohamed-Ali V; Hamsten A
Journal article: SEMINARS IN VASCULAR MEDICINE. 2004;4(2):187-195

The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol.

Nicholls S; Lundman P
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2004;24(3):551-557

Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease

Eriksson P; Deguchi H; Samnegård A; Lundman P; Boquist S; Tornvall P; Ericsson CG; Bergstrand L; Hansson LO; Ye S; Hamsten A
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2003;14(8):749-753

No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction

Lagercrantz J; Bergman M; Lundman P; Tornvall P; Hjemdahl P; Hamsten A; Eriksson P
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2003;91(9):1128-1131

Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1)

Lundman P; Eriksson MJ; Silveira A; Hansson LO; Pernow J; Ericsson CG; Hamsten A; Tornvall P
Journal article: AMERICAN JOURNAL OF CARDIOLOGY. 2002;90(4):447

Acute triglyceridemia and endothelial function.

Lundman P; Tornvall P
Article: ATHEROSCLEROSIS. 2001;159(1):35-41

A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation

Lundman P; Tornvall P; Nilsson L; Pernow J
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001;38(1):111-116

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine

Lundman P; Eriksson MJ; Stühlinger M; Cooke JP; Hamsten A; Tornvall P
Article: CORONARY ARTERY DISEASE. 2000;11(7):523-526

Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction

Kahan T; Lundman P; Olsson G; Wendt M
Article: CIRCULATION. 2000;101(3):227-230

Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease

Björkegren J; Boquist S; Samnegård A; Lundman P; Tornvall P; Ericsson CG; Hamsten A
Article: CIRCULATION. 1997;96(10):3266-3268

Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease

Lundman P; Eriksson M; SchenckGustafsson K; Karpe F; Tornvall P
Article: INTERNATIONAL IMMUNOLOGY. 1995;7(4):625-633

A CD4(+) T-CELL LINE-SECRETED FACTOR, GROWTH-PROMOTING FOR NORMAL AND LEUKEMIC A CELLS, IDENTIFIED AS THIOREDOXIN

ROSEN A; LUNDMAN P; CARLSSON M; BHAVANI K; SRINIVASA BR; KJELLSTROM G; NILSSON K; HOLMGREN A
Show more

All other publications

Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S131

Real-life use of novel glucose lowering agents in coronary artery disease: experience from the SWEDHEART-registry

Ritsinger V; Avander K; Lagerqvist B; Lundman P; Norhammar A
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:1157

Association between high sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population

Cederstrom S; Lundman P; Alfredsson J; Hagstrom E; Ravn-Fischer A; Soderberg S; Yndigegn T; Tornvall P; Jernberg T
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:2279

Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

Yari A; Ueda P; Hagstrom E; Lundman P; Ravn-Fischer A; Soderberg S; Yndigegn T; Jernberg T
Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S433-S434

Prognosis in men and women with atrial fibrillation without and with type 1 and type 2 diabetes: a nationwide propensity-matched cohort study

Karayiannides S; Lundman P; Landstedt-Hallin L; Friberg L; Norhammar A
Corrigendum: CLINICAL BIOCHEMISTRY. 2020;76:49

Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis (vol 64, pg 24, 2019)

Palmer MK; Barter PJ; Lundman P; Nicholls SJ; Toth PP; Karlson BW
Conference publication: DIABETOLOGIA. 2020;63(SUPPL 1):S81-S82

Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report

Karayiannides S; Norhammar A; Landstedt-Hallin L; Friberg L; Lundman P
Conference publication: CIRCULATION. 2019;140

Preoperative Disturbances of Glucose Metabolism and Mortality After Coronary Artery Bypass Grafting

Djupsjo C; Sartipy U; Ivert T; Karayiannides S; Lundman P; Nystrom T; Holzmann MJ; Kuhl J
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:58

Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects

Lind V; Hammar N; Lundman P; Friberg L; Tallback M; Walldius G; Norhammar A
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:4193

Upregulation of protein and gene expression of arginase-1 in patients with ST elevation myocardial infarction

Tengbom J; Cederstrom S; Verouhis D; Sorensson P; Bohm F; Saleh N; Jernberg T; Lundman P; Eriksson P; Gabrielsen A; Caidahl K; Persson J; Folkersen L; Tornvall P; Pernow J
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:429

Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Conference publication: DIABETOLOGIA. 2019;62:S152-S153

Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass grafting

Djupsjo C; Sartipy U; Ivert T; Karayiannides S; Lundman P; Nystrom T; Holzmann M; Kuhl J
Letter: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2018;72(12):1427-1428

Prognosis in Patients With Diabetes Mellitus and STEMI Undergoing Primary PCI

Karayiannides S; Norhammar A; Frobert O; James SK; Lagerqvist B; Lundman P
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:766-767

New candidate genes for plaque rupture in myocardial infarction

Cederstrom S; Lundman P; Folkersen L; Paulsson-Berne G; Eriksson P; Caidahl K; Gabrielsen A; Jernberg T; Persson J; Tornvall P
Conference publication: DIABETOLOGIA. 2017;60:S534-S535

Prognostic differences in men and women with atrial fibrillation and diabetes: a nationwide report

Karayiannides S; Lundman P; Friberg L; Norhammar A
Conference publication: DIABETOLOGIA. 2017;60:S529-S530

Higher one-year mortality in patients with diabetes and ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Lundman P; Karayiannides S; Froebert O; James S; Lagerqvist B; Norhammar A
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:1188

Higher one-year mortality in patients with diabetes mellitus and ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention - a TASTE substudy

Karayiannides S; Norhammar A; Froebert O; James S; Lagerqvist B; Lundman P
Conference publication: DIABETOLOGIA. 2016;59:S551

High overall cardiovascular risk and mortality in patients with atrial fibrillation suffering from diabetes: a nationwide report

Karayiannides S; Lundman P; Fiberg L; Norhammar A
Conference publication: ATHEROSCLEROSIS. 2015;241(1):E202-E203

PREDICTING THE REDUCTION IN RISK OF CARDIOVASCULAR EVENTS WITH HIGH-INTENSITY STATIN TREATMENT: A VOYAGER ANALYSIS

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2015;241(1):E21-E22

ESTIMATING THE REDUCTION IN 10-YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK WITH STATIN THERAPY: A VOYAGER META-ANALYSIS

Palmer M; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
Conference publication: EUROPEAN HEART JOURNAL. 2015;36:1151

Estimating the reduction in 10-year atherosclerotic cardiovascular disease risk with statin therapy: a VOYAGER meta-analysis

Palmer MK; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
Conference publication: DIABETOLOGIA. 2015;58:S554-S555

Long-term clinical outcomes in patients with acute coronary syndrome and dysglycaemia

Kuhl J; Jorneskog G; Bengtsson M; Lundman P; Kalani M
Conference publication: CARDIOLOGY. 2015;131:28-29

Reductions in Low-Density Lipoprotein Cholesterol and Triglyceride with Statins in Patients with Hypertriglyceridaemia: Results from VOYAGER

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: CARDIOLOGY. 2015;131:26-27

Distribution of LDL-C Reduction with Atorvastatin, Rosuvastatin and Simvastatin: A VOYAGER Meta-Analysis

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: CARDIOLOGY. 2015;131:20

Equipotent Effects of Rosuvastatin, Atorvastatin and Simvastatin on LDL-C Reduction: Results from the Voyager Meta-Analysis

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2014;235(2):E295

VARIABILITY OF LDL-C RESPONSE WITH DIFFERENT DOSES OF SIMVASTATIN, ATORVASTATIN AND ROSUVASTATIN: RESULTS FROM VOYAGER

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2014;235(2):E11-E12

ATTAINMENT OF THE ANTICIPATED >=50% REDUCTION IN LDL-C IN THE FOUR ACC/AHA GUIDELINES STATIN BENEFIT GROUPS: A VOYAGER META-ANALYSIS

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: ATHEROSCLEROSIS. 2014;235(2):E35

DOSES OF ROSUVASTATIN, ATORVASTATIN AND SIMVASTATIN INDUCING AN EQUIPOTENT EFFECT ON LDL-C: RESULTS FROM THE VOYAGER META-ANALYSIS

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:679

To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in the four statin benefit groups identified by the ACC/AHA 2013 guidelines? A VOYAGER meta-analysis

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:217

Impact of statin therapy on low-density lipoprotein cholesterol and triglyceride levels in patients with hypertriglyceridaemia: a VOYAGER meta-analysis

Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2013;34:793

The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations

Hage C; Brismar K; Lundman P; Mellbin L; Ryden L
Conference publication: EUROPEAN HEART JOURNAL. 2012;33:883-884

The DPP-IV inhibitor sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities

Hage C; Brismar KB; Efendic SE; Lundman PL; Ryden LR; Mellbin LGM
Conference publication: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):164

EFFECT OF ROSUVASTATIN AND ATORVASTATIN DOSE ON LDL-C <70MG/DL GOAL ATTAINMENT IN PATIENTS WITH DIABETES MELLITUS: RESULTS FROM VOYAGER

Karlson BW; Barter PJ; Palmer MK; Lundman P; Nicholls SJ
Conference publication: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):164

FAVOURABLE IMPACT ON LIPID LEVELS OF INCREASING STATIN DOSE IN HIGH-RISK PATIENTS WITH VERY HIGH BASELINE LDL-C: RESULTS FROM VOYAGER

Lundman P; Palmer MK; Karlson BW; Barter PJ; Nicholls SJ
Corrigendum: JOURNAL OF INTERNAL MEDICINE. 2011;269(4):468

Low plasma adiponectin concentration is associated with myocardial infarction in young individuals (vol 268, pg 194, 2010)

Persson J; Lindberg K; Gustafsson TP; Eriksson P; Paulsson-Berne G; Lundman P
Conference publication: EUROPEAN HEART JOURNAL. 2011;32:227

Impact of diabetes on LDL-cholesterol target achievement in patients with cardiovascular disease in clinical practice in Europe and Canada: results of the dyslipidemia international study

Gitt AK; Leiter L; Lundman P; Drexel H; Ferrieres J; Gonzalez-Juanatey JR; Pedersen T; Thomsen KK; Wood D; Kastelein JP
Conference publication: EUROPEAN HEART JOURNAL. 2011;32:342

Baseline LDL-C and choice and dose of statin as determinants of LDL-C goal achievement: meta-analysis from the VOYAGER database

Karlson BW; Nicholls SJ; Lundman P; Barter PJ; Palmer MK
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2010;11(2):119-120

EFFECTS OF AGE AND STATIN DOSE ON LIPID LEVELS: RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS

Nicholls SJ; Lundman P; Brandrup-Wognsen G; Palmer M; Barter PJ
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2010;11(2):75

DOES GENDER IMPACT ON STATIN DOSE RESPONSE? RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS

Lundman P; Nicholls SJ; Brandrup-Wognsen G; Palmer M; Barter PJ
Review: JOURNAL OF CARDIOVASCULAR RISK. 2010;17 Suppl 1:S20-S24

Diabetic dyslipidemia: extending the target beyond LDL cholesterol.

Nicholls SJ; Lundman P; Tardif J-C
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:391

Impact of increasing statin dose on the ratio of atherogenic to protective lipid parameters: insights from the VOYAGER individual patient data meta-analysis

Nicholls SJ; Lundman P; Brandrup-Wognsen G; Palmer MK; Barter PJ
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:373

Predictors of LDL-cholesterol goal achievement in secondary prevention in Europe and Canada: results of the Dyslipidemia International Study

Gitt AK; Juenger C; Smolka W; Bestehorn K; Lundman P; Leiter L; Pedersen T; Gonzalez-Juanatey J; Chazelle F; Kastelein J
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:373

Germany lags behind other European Countries and Canada in LDL-cholesterol goal achievement according to existing guidelines: results of the Dyslipidemia International Study

Gitt AK; Juenger C; Smolka W; Bestehorn K; Leiter L; Lundman P; Gonzalez-Juanatey J; Pedersen T; Chazelle F; Kastelein J
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:604-605

The strong association between renal function and mortality is not influenced by chosen reperfusion strategy - data from the SWEDEHEART registry

Szummer K; Lundman P; Jacobson SH; Schon S; Lindback J; Wallentin L; Jernberg T
Conference publication: EUROPEAN HEART JOURNAL. 2009;30:514-515

Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: Results from the Dyslipidemia International Study (DYSIS)

Thomsen KK; Lundman P; Salling S; Journath G; Pedersen T
Conference publication: DIABETOLOGIA. 2009;52:S131

High prevalence of residual dyslipidemia in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidemia International Study

Drexel H; Feely J; Ferrieres J; Gitt A; Gonzalez-Juanatey J-R; Thomsen KK; Lundman P; da Silva PM; Pedersen T; Wood D; Chazelle F; Hackett M; Kastelein J; Leiter L
Conference publication: ATHEROSCLEROSIS SUPPLEMENTS. 2009;10(2)

LOW ADIPONECTIN CONCENTRATION IS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND LEVELS ARE INFLUENCED BY GENETIC VARIANTS

Persson J; Eriksson P; Gustafsson T; Berne GP; Lundman P
Conference publication: CARDIOLOGY. 2009;113:116

Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: results from the Dyslipidemia International Study (DYSIS)

Thomsen KK; Salling S; Lundman P; Journath G; Pedersen T
Conference publication: CIRCULATION. 2009;120(18):S501

Statin Use After Myocardial linfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

Szummer K; Lundman P; Jacobson S; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Conference publication: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009;53(10):A354

Cockcroft-Gault Is Better Than the Modi. cation of Diet in Renal Disease Study Formula to Predict Outcome Following a Myocardial Infarction-Data From Swedish Register of Information and Knowledge

Szummer K; Jacobson SH; Lundman P; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Conference publication: CIRCULATION. 2008;118(18):S969

Early Invasive Therapy in Non-ST-elevation Myocardial Infarction Improves Survival Although Benefit Declines with Worsening Renal Function - Data from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)

Szummer K; Lundman P; Jacobson S; Schon S; Lindback J; Stenestrand U; Wallentin L; Jemberg T
Conference publication: CIRCULATION. 2008;118(18):S966-S967

Myocardial Infarction, Clinical Characteristics and Prognosis across Five Renal Function Stages - Data from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)

Szummer K; Lundman P; Jacobson S; Schon S; Lindback J; Stenestrand U; Wallentin L; Jernberg T
Conference publication: CIRCULATION. 2005;112(17):U435-U436

Consumption of saturated fat impairs endothelial function and the anti-inflammatory properties of high density lipoproteins

Nicholls SJ; Lundman P; Harmer J; Cutri B; Griffiths K; Rye KA; Barter PJ; Celermajer DS
Conference publication: CIRCULATION. 2005;112(17):U43

Consumption of saturated fat impairs endothelial function and the antiinflammatory properties of high-density lipoproteins

Nicholls SJ; Lundman P; Harmer J; Cutri B; Griffiths K; Rye KA; Barter PJ; Celermajer DS
Letter: CARDIOLOGY. 2003;99(4):214-215

A case report supporting multiple plaque ruptures in CAD

Tornvall P; Jensen J; Persson H; Lundman P
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):323

Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease

Eriksson P; Deguchi H; Samnegard A; Lundman P; Boquist S; Tornvall P; Ericsson CG; Bergstrand L; Hansson LO; Hamsten A
Thesis / dissertation: 2001

Effects of triglycerides on the endothelium

Lundman, Pia
Conference publication: CIRCULATION. 2001;104(17):240

Mild to moderate hypertriglyceridemia is associated with endothelial dysfunction and low-grade inflammation

Lundman PIM; Eriksson MJ; Stuehlinger M; Cooke JP; Tornvall P
Letter: CIRCULATION. 1998;98(17):1827

Triglycerides and postprandial angina - Response

Lundman P; Tornvall P; Eriksson M; Schenck-Gustafsson K; Karpe F
Show more

Grants

Diabetes and cardiovascular disease

Swedish Heart-Lung Foundation

1 January 2019 - 31 December 2019
The Myocardial Infarction and new treatment with Metformin study (MIMET) - a registry based randomised controlled trial

Swedish Research Council

1 January 2019 - 31 December 2021

Employments

Senior Lecturer/Senior Physician, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2015-

Degrees and Education

Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2001
University Medical Degree, Karolinska Institutet, 1993

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI